|
5-Fluorouracil (i.v.), capecitabine and tegafur containing products
|
|
The risk of birth defects from the recently published epidemiological studies for Zofran (Ondansetron)
|
|
New important information on safety of medicine Esmya, 5 mg tablets
|
|
Domperidone-containing products: reminder of indication and contraindications related to serious cardiac side efefcts
|
|
Methotrexate
|
|
Kadcyla: HCP Educational Information
|
|
Tecentriq (atezolizumab)
|
|
Actemra (tocilizumab)
|
|
Systemic and inhaled fluoroquinolones: risk of aortic aneurysm and dissection
|
|
ADENURIC (febuxostat): increased risk of cardiovascular death and all-cause mortality in patients treated with febuxostat in the CARES study
|
